What is PEAK Research?
Established in 2011, PEAK Research operates as a specialized clinical research organization dedicated to the execution of ethical and efficient medical trials. With a leadership team boasting over 50 years of collective experience, the firm has cultivated a reputation for data integrity and operational excellence. Operating out of facilities in Upper St. Clair, Pennsylvania, and Fort Mill, South Carolina, the company provides end-to-end research support. Their market position is defined by a commitment to high-quality clinical outputs, having successfully collaborated with more than 40 sponsors to date. The organization serves as a critical partner in the pharmaceutical and biotech development pipeline, ensuring that complex clinical protocols are managed with precision and regulatory compliance.
How much funding has PEAK Research raised?
PEAK Research has raised a total of $62K across 1 funding round:
Debt
$62K
Debt (2021): $62K with participation from PPP
Key Investors in PEAK Research
PPP
Public-Private Partnership
What's next for PEAK Research?
With the infusion of this recent capital, PEAK Research is poised to enter a new phase of strategic growth. The organization is expected to focus on expanding its site capacity and investing in advanced data management technologies to further streamline trial timelines. As the demand for high-integrity clinical data continues to rise, the company's ability to maintain its rigorous standards while scaling will be a key performance indicator. Future initiatives will likely involve broadening their therapeutic expertise and deepening relationships with existing sponsors, solidifying their role as a premier provider in the clinical research landscape. This funding serves as a catalyst for long-term sustainability and competitive differentiation in an increasingly complex regulatory environment.
See full PEAK Research company page
